Cite

HARVARD Citation

    Scott, A. et al. (2018). 'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma. Leukemia & lymphoma. 59 (6), pp. 1514-1516. [Online]. 
  
Back to record